11:54 AM EST - BriaCell Therapeutics Corp : Announces that its lead product candidate, Bria-IMT™, will be featured in three posters during the 2022 San Antonio Breast Cancer Symposium® taking place December 6-10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. BriaCell Therapeutics Corp
shares T.BCT are trading unchanged at $7.84.
